⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2383252 | 0.71 | — | — | |
| SCHEMBL11648251 | 0.69 | — | — | |
| SCHEMBL834665 | 0.69 | — | — | |
| SCHEMBL8406569 | 0.69 | — | — | |
| SCHEMBL834417 | 0.67 | — | — | |
| SCHEMBL1032378 | 0.67 | — | — | |
| SCHEMBL5402282 | 0.67 | — | — | |
| SCHEMBL8406567 | 0.67 | — | — | |
| SCHEMBL1030414 | 0.67 | — | — | |
| SCHEMBL13719051 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024131265-A1 | COMPOUND FOR TREATING PI3Kγ-MEDIATED DISEASES AND USE THEREOF | 中国科学院合肥物质科学研究院 | 2024-06-27 | — | — | WO | claimed |
| CN-118239953-A | Compounds for the treatment of PI3K gamma mediated diseases and uses thereof | 中国科学院合肥物质科学研究院 | 2024-06-25 | — | — | CN | claimed |
| WO-2024094170-A1 | INHIBITOR OF UBIQUITIN-SPECIFIC PROTEASE 1 AND USE THEREOF | 深圳晶泰科技有限公司 | 2024-05-10 | — | — | WO | claimed |
| US-20150080381-A1 | METHODS OF TREATING ALOPECIA AND ACNE | IRONWOOD PHARMACEUTICALS, INC. | 2015-03-19 | — | — | US | claimed |
| US-8674115-B2 | CRTH2 modulators | IRONWOOD PHARMACEUTICALS, INC. (US) | 2014-03-18 | — | — | US | claimed |
| WO-2013155422-A1 | METHODS OF TREATING ALOPECIA AND ACNE | IRONWOOD PHARMACEUTICALS, INC. (US) | 2013-10-17 | — | — | WO | claimed |
| EP-2516416-A1 | CRTH2 MODULATORS | Ironwood Pharmaceuticals, Inc. (US) | 2012-10-31 | — | — | EP | claimed |
| WO-2011079007-A1 | CRTH2 MODULATORS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2011-06-30 | — | — | WO | claimed |
| US-20110150834-A1 | CRTH2 MODULATORS | WELLS FARGO BANK, NATIONAL ASSOCIATION | 2011-06-23 | — | — | US | claimed |
| US-5466684-A | 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1995-11-14 | — | — | US | claimed |
| US-5328902-A | Antibiotics | AMERICAN CYANAMID CO. (US) | 1994-07-12 | — | — | US | claimed |
| EP-0326054-B1 | PROCESS FOR PURIFICATION OF 2,2,3,3-TETRAFLUOROOXETANE | DAIKIN INDUSTRIES, LIMITED (JP) | 1992-04-15 | — | — | EP | claimed |
| EP-0258911-B1 | PROCESS FOR PREPARING 2,2,3-TRIFLUOROPROPIONYL FLUORIDE | DAIKIN INDUSTRIES, LIMITED (JP) | 1990-10-31 | — | — | EP | claimed |
| EP-0296749-A1 | (Substituted aralkyl) heterocyclic compounds | ZENECA LIMITED (GB) | 1988-12-28 | — | — | EP | claimed |
| WO-2024131265-A1 | COMPOUND FOR TREATING PI3Kγ-MEDIATED DISEASES AND USE THEREOF | 中国科学院合肥物质科学研究院 | 2024-06-27 | — | — | WO | disclosed |
| CN-118239953-A | Compounds for the treatment of PI3K gamma mediated diseases and uses thereof | 中国科学院合肥物质科学研究院 | 2024-06-25 | — | — | CN | disclosed |
| EP-3957627-B1 | 6-MEMBERED HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | SHIONOGI & CO (JP) | 2024-06-19 | — | — | EP | disclosed |
| US-4011341-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-3989840-A | Control of animal parasites with ring-substituted N-(2,2-difluoroalkanoyl)-O-phenylenediamines | ELI LILLY AND COMPANY (US) | 1976-11-02 | — | — | US | disclosed |
| US-3962263-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |